Teva Pharmaceutical Industries Ltd.

5 Basel Street, PO Box 3190,
Petach Tikva, 49131
Israel,
+972 3 926 7267
www.tevapharm.com

Teva Pharmaceutical Industries Ltd. is a provider of pharmaceutical company, committed to increasing access to high-quality healthcare by developing, producing and marketing affordable generic drugs as well as innovative and specialty pharmaceuticals and active pharmaceutical ingredients.

M&A Summary

Buy vs Sell

Year ≤ '12 '13 '14 '15 '16 '17 T
Buy (1.8/yr) # 14 1 2 5 1 - 23
vol $29.8B $40M $344M $46.0B $500M $76.7B
Sell (0.6/yr) # 1 1 - 1 1 - 4
vol $36M $13M $586M $635M
  27

Top M&A Advisors

Financial Deals
Sign-up to View
3
Sign-up to View
2
Sign-up to View
2
Legal Deals
Sign-up to View
3
Sign-up to View
1
Sign-up to View
1

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Allergan Generics
$40.5B (2015-07-27)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View
Largest Teva Pharmaceutical Industries Ltd. - Generic Products
$586M (2016-06-21)

According to our data here at Mergr, Teva Pharmaceutical Industries has acquired 23 companies, including 9 in the last 5 years. A total of 3 acquisitions came from private equity firms. It has also divested 4 assets.

Teva Pharmaceutical Industries’ largest acquisition to date was in 2015, when it acquired Allergan Generics for $40.5B. It’s largest disclosed sale occurred in 2016, when it sold Teva Pharmaceutical Industries - Generic Products to Impax Laboratories for $586M. Teva Pharmaceutical Industries has acquired in 7 different US states, and 7 countries. The Company’s most targeted sectors include life science (87%) and distribution (5%).

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 420 life science companies that have made at least 1 acquisition, 25 have acquired at least 5 companies, and 4 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 24 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 4 platform acquisitions.

Join Mergr and gain access to Teva Pharmaceutical Industries’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.1K Private Equity Firms
  • 110K M&A Transactions
  • 120K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.